
S-DMEK in Egypt: First Surgeon — Dr. Ahmed Shaarawy, cornea.clinic Cairo
١٦ أبريل ٢٠٢٦

استشاري جراحة القرنية والليزك
أداة مجانية
DALK · PKP · DMEK · DSAEK — تقدير شخصي فوري بناءً على حالتك
Corneal diseases and endothelial dysfunction affect millions of people worldwide, causing vision loss and potentially permanent blindness if left untreated. In Cairo, patients now have access to advanced cornea transplant procedures through specialized ophthalmologists like Dr. Ahmed Shaarawy, who offers expertise in the latest transplantation techniques. This comprehensive guide explains cornea transplant options, procedural differences, recovery timelines, and why Cairo has become a destination for advanced corneal surgery.
A cornea transplant (keratoplasty) is a surgical procedure in which a diseased or scarred cornea is replaced with healthy donor corneal tissue. The cornea is the clear, dome-shaped front surface of the eye that focuses light onto the retina. When the cornea becomes cloudy, scarred, or swollen, it impedes vision and can cause significant functional disability.
According to the American Academy of Ophthalmology, cornea transplantation is one of the most successful organ transplant procedures globally, with high survival rates. Unlike other organ transplants, corneal tissue does not require blood type matching, and the risk of rejection is relatively low due to the cornea's immune-privileged status.
DMEK represents the most advanced form of corneal transplantation available today. This procedure involves transplanting only the innermost layer of the cornea—the Descemet membrane and its endothelial cells—rather than the full-thickness cornea. The procedure is performed through a micro-incision (2-3mm), making it minimally invasive.
Advanced centers like those led by experienced cornea specialists offer DMEK as a refined technique. DMEK offers several advantages according to peer-reviewed ophthalmology literature: faster visual recovery (vision stabilization typically in 4-8 weeks), minimal corneal scarring, lower rejection rates compared to earlier techniques, and superior final visual outcomes. Studies in peer-reviewed journals document that DMEK grafts have strong survival rates at five years when performed in appropriate cases.
DMEK is ideal for patients with Fuchs endothelial dystrophy, pseudophakic bullous keratopathy, and endothelial failure following prior eye surgery. Because the procedure preserves corneal shape and biomechanics, visual quality is typically excellent, with many patients achieving very good uncorrected vision.
DSAEK is an earlier endothelial keratoplasty technique that preceded DMEK. Like DMEK, it replaces only the inner corneal layers, but the graft is slightly thicker (approximately 150 microns versus 130 microns for DMEK). This increases the refractive impact and can cause mild myopic shift in refraction.
DSAEK was a major advancement when introduced, and remains an effective and well-established option for appropriate candidates. Recovery is moderately rapid, with useful vision returning within 8-12 weeks. DSAEK grafts may experience higher endothelial cell loss over time compared to DMEK, and the thicker graft can occasionally induce astigmatism.
DSAEK may be recommended for patients with severe anatomical factors that make DMEK technically challenging, or in specific cases where patient anatomy suggests DSAEK is optimal. Modern DSAEK outcomes remain excellent for well-selected candidates.
PKP involves transplanting a full-thickness disc of corneal tissue, replacing all five layers of the cornea. This is the most invasive of the three techniques and is now typically reserved for cases where anterior corneal scarring, keratoconus, corneal ectasia, or epithelial/stromal disease necessitates full-thickness replacement.
PKP requires a larger incision (typically 7.5-8.0mm in diameter) and necessitates corneal sutures that remain in place for 12-24 months. Visual recovery is slower, often taking 6-12 months for vision to stabilize. Graft rejection risk is higher with PKP than with endothelial keratoplasty techniques, and the procedure carries a small risk of astigmatism if sutures are placed unevenly.
Despite these considerations, PKP remains essential for anterior corneal disease and offers excellent long-term outcomes when performed by experienced surgeons. Many PKP grafts demonstrate longevity measured in decades with proper post-operative care.
| Procedure | Incision Size | Visual Recovery | Rejection Risk | Vision Quality | Best For |
|---|---|---|---|---|---|
| DMEK | 2-3mm micro-incision | 4-8 weeks | Lowest among options | Excellent | Fuchs dystrophy, bullous keratopathy, minimal scarring |
| DSAEK | 3-4mm incision | 8-12 weeks | Moderate | Very good | Endothelial disease, technical DMEK challenges |
| PKP | 7.5-8.0mm larger incision | 6-12 months | Highest among options | Good to excellent | Anterior scarring, keratoconus, advanced ectasia |
Cornea transplantation is indicated when corneal pathology significantly impairs vision and cannot be managed with glasses, contact lenses, or medical therapy. Common indications include:
Not all patients are candidates for all procedure types. Candidates for DMEK require adequate endothelial cell density and minimal anterior scarring. PKP candidates often have anterior disease unsuitable for endothelial keratoplasty. A comprehensive pre-operative evaluation determines the optimal procedure for each patient.
Before cornea transplant surgery, patients undergo detailed testing including:
This comprehensive evaluation ensures appropriate candidate selection and optimal surgical outcomes.
DMEK is performed under operating microscope magnification with topical anesthesia. The surgeon creates a small anterior chamber incision, then carefully peels away the diseased Descemet membrane using a specialized instrument. The donor graft is then inserted through the small incision on an injector tip, unfolded inside the eye, and positioned against the posterior corneal surface. An air bubble is injected to press the graft in place while the endothelium adheres. The procedure typically requires 20-45 minutes depending on complexity and surgical factors.
DSAEK follows similar principles but involves a slightly thicker graft. A graft of appropriate thickness is created and the graft is inserted through a slightly larger incision and positioned posteriorly. An air bubble is used to secure it. DSAEK typically requires 30-50 minutes.
PKP involves full-thickness corneal replacement. The surgeon uses a trephine (circular blade) to remove a disc of diseased cornea. A size-matched donor cornea is positioned and secured with sutures around the graft-host junction. Sutures remain in place for 12-24 months while the cornea heals. Surgery typically requires 60-90 minutes, depending on complexity.
After DMEK or DSAEK, patients must maintain strict positioning to keep the air bubble pressing the graft in place. Topical antibiotics and corticosteroids are used frequently. Vision remains blurry during this phase. For PKP, a protective eye patch is worn, and activity is restricted.
With DMEK/DSAEK, the air bubble reabsorbs naturally. Vision begins improving gradually. For PKP, vision remains blurred; sutures support the graft. All patients attend frequent follow-up appointments to monitor graft health and watch for signs of inflammation or rejection.
DMEK patients typically achieve functional vision within weeks. DSAEK patients require a longer period for recovery. PKP patients experience slower progress, with useful vision developing over months. Refractive error gradually stabilizes during this period. Topical corticosteroids are continued and gradually reduced.
Vision continues to refine. For PKP patients, sutures are typically removed after several months post-operatively, after which vision may shift. Long-term follow-up includes regular ophthalmology visits to monitor graft survival, screen for rejection, manage refraction, and detect complications.
Corneal graft rejection occurs when the immune system attacks donor tissue. Symptoms include eye redness, pain, tearing, light sensitivity, and sudden vision decrease. Unlike systemic organ rejection, corneal rejection can sometimes be reversed with aggressive topical corticosteroid therapy if caught early.
Rejection risk increases with:
Prevention involves strict adherence to topical corticosteroid regimens (often lifelong, though at lower frequency over time) and prompt reporting of any eye symptoms to the surgeon.
While cornea transplantation has high success rates, potential complications include:
Experienced surgeons minimize these risks through refined surgical technique and careful patient selection. Outcomes vary based on disease etiology, patient compliance, and individual factors.
Dr. Ahmed Shaarawy is an experienced cornea specialist offering comprehensive corneal surgical services in Cairo. His background and expertise include:
Dr. Shaarawy combines international training, extensive surgical experience, and commitment to personalized patient care to deliver corneal surgery services in Cairo.
Cornea transplant surgery costs in Cairo are significantly lower than in Western countries, while maintaining professional quality standards. Pricing varies based on the procedure type and individual factors:
These fees typically include the surgical procedure, donor corneal tissue, post-operative medications, and follow-up visits for the first 3-6 months. Patients should contact the clinic directly for detailed pricing information and to discuss payment options and financing possibilities.
Cairo has emerged as a destination for advanced corneal surgery due to several factors:
How long does a cornea transplant last?
Cornea graft longevity varies depending on graft type, patient age, underlying disease, and post-operative compliance. Grafts may function for many years or decades with proper care and management. Individual results vary considerably.
Will I need glasses after cornea transplant?
Many patients require glasses or contact lenses after cornea transplant to achieve optimal vision. The need for corrective lenses depends on the procedure type, the patient's pre-operative refraction, and individual healing patterns. Your refraction stabilizes several months post-operatively, at which point glasses can be prescribed if needed.
Can cornea transplant be rejected?
Yes, corneal graft rejection is possible. However, with modern surgical techniques and post-operative care, rejection rates are relatively low. Early recognition of rejection symptoms (redness, pain, vision decrease) and prompt treatment with topical corticosteroids can help preserve graft function. Lifelong topical corticosteroid drops at decreasing frequency are typically recommended to reduce rejection risk.
How long is the surgery?
DMEK typically takes 20-45 minutes. DSAEK requires 30-50 minutes. PKP often takes 60-90 minutes depending on complexity. These times reflect actual surgery time and do not include pre-operative preparation or post-operative observation.
When can I return to normal activities?
Post-operative activity restrictions vary by procedure type. Patients should follow their surgeon's specific recommendations. Generally, patients progress from strict positioning requirements to gradually increasing activity levels over weeks and months. Your surgeon will provide detailed post-operative activity guidelines tailored to your procedure and healing.
What is the success rate for cornea transplant?
Cornea transplant success rates vary based on procedure type, indication, patient selection, and surgeon expertise. Success is typically measured by graft survival (absence of graft failure requiring re-grafting) and achievement of functional vision. Individual results depend on many factors, and your surgeon can discuss expected outcomes based on your specific situation.
If you suffer from corneal disease, endothelial dysfunction, or vision loss due to corneal scarring, cornea transplant surgery may be an option to restore your sight. Dr. Ahmed Shaarawy offers comprehensive surgical evaluation and personalized treatment planning.
Contact Information:
Schedule your comprehensive pre-operative consultation today. Dr. Shaarawy will assess your corneal condition, discuss your surgical options, and develop a personalized treatment plan based on your specific needs.

مدرس بمعهد بحوث أمراض العيون واستشاري جراحة القرنية والليزك. حاصل على زمالة سريرية وبحثية من معهد ديفرز للعيون — أوريجون، أمريكا تحت إشراف البروفيسور مارك تيري. أول من أجرى زراعة القرنية البطانية بتقنية S-DMEK في مصر والمنطقة العربية. أبحاث منشورة في الأكاديمية الأمريكية لطب العيون (AAO).
المزيد عن الدكتوراحجز موعدك الآن

١٦ أبريل ٢٠٢٦

١٥ أبريل ٢٠٢٦

١٤ أبريل ٢٠٢٦

٣ أبريل ٢٠٢٦
سجّل بريدك لتصلك مقالات مبسطة عن صحة العيون وجراحات القرنية أولاً بأول
هل تريد معرفة تكلفة العملية؟
احسب التكلفة الآن